M&T Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$46.8M Sell
771,822
-4,861
-0.6% -$283K 0.16% 114
2025
Q4
$41.9M Buy
776,683
+13,307
+2% +$640K 0.13% 126
2025
Q3
$34.4M Sell
763,376
-49,299
-6% -$2.3M 0.12% 148
2025
Q2
$37.6M Sell
812,675
-23,588
-3% -$1.16M 0.13% 139
2025
Q1
$51M Sell
836,263
-48,250
-5% -$2.81M 0.19% 111
2024
Q4
$50M Sell
884,513
-16,834
-2% -$941K 0.17% 114
2024
Q3
$46.6M Sell
901,347
-42,123
-4% -$1.98M 0.15% 119
2024
Q2
$39.2M Sell
943,470
-67,636
-7% -$3.03M 0.13% 128
2024
Q1
$54.8M Sell
1,011,106
-52,543
-5% -$2.68M 0.19% 110
2023
Q4
$54.6M Sell
1,063,649
-344,568
-24% -$18.1M 0.2% 109
2023
Q3
$81.7M Sell
1,408,217
-52,147
-4% -$3.2M 0.33% 73
2023
Q2
$93.4M Sell
1,460,364
-20,336
-1% -$1.36M 0.35% 69
2023
Q1
$103M Sell
1,480,700
-15,832
-1% -$1.12M 0.4% 62
2022
Q4
$108M Buy
1,496,532
+21,431
+1% +$1.62M 0.43% 60
2022
Q3
$105M Buy
1,475,101
+52,913
+4% +$3.84M 0.47% 52
2022
Q2
$105M Buy
1,422,188
+55,101
+4% +$4.2M 0.49% 45
2022
Q1
$99.8M Buy
1,367,087
+30,881
+2% +$2.07M 0.44% 54
2021
Q4
$83.3M Sell
1,336,206
-33,249
-2% -$1.95M 0.35% 70
2021
Q3
$81M Sell
1,369,455
-72,256
-5% -$4.76M 0.36% 67
2021
Q2
$96.3M Sell
1,441,711
-63,453
-4% -$4.14M 0.42% 54
2021
Q1
$95M Sell
1,505,164
-85,992
-5% -$5.35M 0.41% 53
2020
Q4
$98.7M Sell
1,591,156
-22,798
-1% -$1.4M 0.43% 47
2020
Q3
$96.3M Sell
1,613,954
-14,426
-0.9% -$868K 0.47% 45
2020
Q2
$94.8M Sell
1,628,380
-20,927
-1% -$1.25M 0.51% 46
2020
Q1
$91M Sell
1,649,307
-130,645
-7% -$7.99M 0.54% 39
2019
Q4
$108M Buy
1,779,952
+189,654
+12% +$10.9M 0.51% 33
2019
Q3
$80.6M Sell
1,590,298
-5,972
-0.4% -$281K 0.4% 61
2019
Q2
$72.4M Buy
1,596,270
+396,703
+33% +$18.5M 0.38% 70
2019
Q1
$57.2M Sell
1,199,567
-31,901
-3% -$1.59M 0.3% 91
2018
Q4
$64M Sell
1,231,468
-63,190
-5% -$3.4M 0.37% 69
2018
Q3
$80.4M Buy
1,294,658
+6,670
+0.5% +$396K 0.4% 59
2018
Q2
$71.3M Sell
1,287,988
-380,505
-23% -$20.6M 0.38% 65
2018
Q1
$106M Sell
1,668,493
-4,705
-0.3% -$303K 0.57% 42
2017
Q4
$103M Sell
1,673,198
-10,717
-0.6% -$670K 0.54% 42
2017
Q3
$107M Buy
1,683,915
+3,521
+0.2% +$206K 0.58% 38
2017
Q2
$93.6M Sell
1,680,394
-29,734
-2% -$1.62M 0.55% 39
2017
Q1
$93M Buy
1,710,128
+64,403
+4% +$3.53M 0.56% 41
2016
Q4
$96.2M Buy
1,645,725
+75,301
+5% +$4.12M 0.6% 36
2016
Q3
$84.7M Buy
1,570,424
+167,171
+12% +$10.7M 0.54% 38
2016
Q2
$103M Buy
1,403,253
+15,823
+1% +$1.12M 0.69% 30
2016
Q1
$88.6M Sell
1,387,430
-77,735
-5% -$4.9M 0.6% 36
2015
Q4
$101M Buy
1,465,165
+8,630
+0.6% +$570K 0.67% 33
2015
Q3
$86.2M Sell
1,456,535
-353,818
-20% -$22.4M 0.59% 34
2015
Q2
$120M Buy
1,810,353
+3,632
+0.2% +$239K 0.73% 29
2015
Q1
$117M Sell
1,806,721
-14,539
-0.8% -$910K 0.73% 27
2014
Q4
$108M Buy
1,821,260
+4,490
+0.2% +$253K 0.67% 27
2014
Q3
$93M Buy
1,816,770
+1,351,781
+291% +$67.5M 0.6% 31
2014
Q2
$22.6M Sell
464,989
-144,659
-24% -$7.13M 0.94% 23
2014
Q1
$31.7M Sell
609,648
-10,578
-2% -$563K 1.31% 13
2013
Q4
$33M Sell
620,226
-20,589
-3% -$1.05M 1.38% 12
2013
Q3
$29.7M Sell
640,815
-26,329
-4% -$1.16M 1.42% 14
2013
Q2
$29.8M Buy
+667,144
New +$29M 1.45% 14

Other funds holding BMY

M&T Bank's BMY Position: Q1 2026 in Review

M&T Bank reduced its Bristol-Myers Squibb (BMY) stake by 0.63% in Q1 2026, selling an estimated $283K and leaving 771,822 shares worth $46.8M. The position accounts for 0.16% of the portfolio, ranked #114.

M&T Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $120M in Q2 2015. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • M&T Bank held 771,822 shares of Bristol-Myers Squibb worth $46.8M as of Q1 2026.
  • M&T Bank sold 4,861 Bristol-Myers Squibb shares in Q1 2026, an estimated $283K.
  • Bristol-Myers Squibb made up 0.16% of M&T Bank's portfolio in Q1 2026, its #114 holding.
  • M&T Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • M&T Bank's Bristol-Myers Squibb position peaked at $120M in Q2 2015.
  • 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.